Safety and Efficacy of a 3-Year Therapy With Cinacalcet in Persistent Hyperparathyroidism After Renal Transplant
- 20 March 2020
- journal article
- research article
- Published by Elsevier BV in Transplantation Proceedings
- Vol. 52 (5), 1284-1286
- https://doi.org/10.1016/j.transproceed.2020.02.024
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A Randomized Study Comparing Parathyroidectomy with Cinacalcet for Treating Hypercalcemia in Kidney Allograft Recipients with HyperparathyroidismJournal of the American Society of Nephrology, 2015
- Long-Term Clinical Practice Experience with Cinacalcet for Treatment of Hypercalcemic Hyperparathyroidism after Kidney TransplantationBioMed Research International, 2015
- Cinacalcet for hypercalcaemic secondary hyperparathyroidism after renal transplantation: a multicentre, retrospective, 3‐year studyNephrology, 2013
- Manejo de la hipercalcemia tras el trasplante renal2013
- Persistent Hyperparathyroidism Is a Major Risk Factor for Fractures in the Five Years After Kidney TransplantationAmerican Journal of Transplantation, 2013
- Recovery Versus Persistence of Disordered Mineral Metabolism in Kidney Transplant RecipientsSeminars in Nephrology, 2013
- Impact of parathyroidectomy on allograft outcomes in kidney transplantationTransplant International, 2012
- Tertiary Hyperparathyroidism in Kidney Transplant RecipientsTransplantation, 2012
- The Regulation of Parathyroid Hormone Secretion and SynthesisJournal of the American Society of Nephrology, 2011
- A New Equation to Estimate Glomerular Filtration RateAnnals of Internal Medicine, 2009